Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Jul
15
2016
 Patent Office Adds Another After Final Option for Applicants – P3 Sheppard, Mullin, Richter & Hampton LLP
Jul
15
2016
 Graymont Pa, Inc: Summary of NLRB Decisions for Week of June 27 – July 1, 2016 Barnes & Thornburg LLP
Jul
14
2016
 Janssen Seeks Injunction Against Remicade Biosimilar Based On Cell Culture Patent Foley & Lardner LLP
Jul
14
2016
 En Banc: Federal Circuit Provides Guidance on Application of On-Sale Bar to Contract Manufacturers Sheppard, Mullin, Richter & Hampton LLP
Jul
14
2016
 Institution of Inter Partes Review Denied for Twilio Inc. v. TeleSign Corporation (IPR2016-00450) Faegre Drinker
Jul
13
2016
 Federal Circuit Clarifies When an Invention is the Subject of a Commercial Sale or Offer for Sale for Purposes of the On-Sale Bar Michael Best & Friedrich LLP
Jul
13
2016
 Federal Circuit Clarifies the “Commercial Offer for Sale” Prong of the On-Sale Bar Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
13
2016
 Overruling Precedent, NLRB Holds Bargaining Units of Jointly and Solely Employed Employees May Elect Union Representative Absent Consent of Their Employers Jackson Lewis P.C.
Jul
13
2016
 Intellectual Property: What Type of Sale Constitutes an On-Sale Bar? Mintz
Jul
13
2016
 Federal Circuit Defines Commercial Sale For ‘On-Sale’ Bar Morgan, Lewis & Bockius LLP
Jul
12
2016
 Federal Circuit Provides Guidance on When Outsourcing Manufacturing Constitutes a Patent-Invalidating Sale Barnes & Thornburg LLP
Jul
12
2016
 Tax Court Clarifies the Rules and Grants IRS’s Motion to Compel Nonconsensual Depositions McDermott Will & Schulte LLP
Jul
11
2016
 NLRB Ruling: Temps Can be Part of Bargaining Units Barnes & Thornburg LLP
Jul
8
2016
 PTO Litigation Center Report – July 8, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
8
2016
 USPTO Fast-Tracks Cancer Immunotherapy Patent Applications Mintz
Jul
8
2016
 Federal Circuit Backs Amgen on Key Provision of Biosimilars Statute Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
7
2016
 TTAB Precedential Decision: Time Limit for Adding Claims Is Tolled by Filing of Cancellation Within Registration’s Fifth Anniversary Sheppard, Mullin, Richter & Hampton LLP
Jul
7
2016
 Lightweight Fabric: Admissibility Versus Weight at PTAB Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
7
2016
 AIA Estoppel Provisions Clarified: America Invents Act Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
7
2016
 PTO Litigation Center Report – July 7, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
7
2016
 Federal Circuit Finds Cryopreservation Method Patent Eligible Foley & Lardner LLP
Jul
6
2016
 Federal Circuit Rules Biosimilar Notice of Commercial Marketing Mandatory Michael Best & Friedrich LLP
Jul
6
2016
 Supreme Court Gives Deference to USPTO in Post Grant Proceedings Hunton Andrews Kurth
Jul
6
2016
 Apotex—Biosimilars Must Provide 180-Day Marketing Notice After FDA Approval Morgan, Lewis & Bockius LLP
Jul
6
2016
 Focusing on Second Step of Alice, Federal Circuit Finds Inventive Concept in Software Patent in BASCOM Mintz
Jul
6
2016
 PTO Litigation Center Report – July 6, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
6
2016
 Federal Circuit's Primer on Patent-Eligibility in Rapid Litig. v. CellzDirect Foley & Lardner LLP
Jul
6
2016
 Fed Circuit’s “Amgen v. Apotex” Decision: Clarification of BPCIA Riddle (Unless, of course, Supreme Court Steps In) Mintz
Jul
6
2016
 Federal Circuit Requires 180 Day Notice For All Biosimilars, Even After Patent Dance Foley & Lardner LLP
Jul
5
2016
 Rapid Litigation v. CellzDirect – A Break in the Section 101 Wall Schwegman, Lundberg & Woessner, P.A.
Jul
5
2016
 BASCOM—Federal Circuit Holds Internet Content Filtering Patent Passes Alice Test Morgan, Lewis & Bockius LLP
Jul
5
2016
 Bascom v. AT&T — Patent Eligibility Meet Patentability Schwegman, Lundberg & Woessner, P.A.
Jul
5
2016
 PTO Litigation Center Report – July 5, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
5
2016
 Supreme Court Declines Sequenom Review Foley & Lardner LLP
Jul
1
2016
 No Approval for Generic Product for Treatment of Rosacea McDermott Will & Schulte LLP
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters